-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Under the influence of policy liberalization and technological innovation, the pattern of drug circulation industry has changed, and the survival of small and medium-sized pharmacies, especially monosomal pharmacies, has become more pessimistic.
November 27, Tao Jianhong, deputy director of the Southern Institute of Pharmaceutical Economics of the State Food and Drug Administration, revealed at the Great Health Industry Development Forum under the supply-side reform strategy that the pharmaceutical distribution industry is undergoing a major reshuffle, including the Ministry of Commerce, the State Food and Drug Administration and other departments have drafted "guidance on promoting the classification and classification management of retail pharmacies (draft for comments)" (hereinafter referred to as the "Draft for Comments").
according to the Southern Institute of Pharmaceutical Economics, as of May 2017, there were 460,600 retail pharmacies nationwide, and the number of single pharmacies decreased gradually, with 203,000 and 190,000 disappearing in 2015 and 2016, respectively. Tao Jianhong pointed out that under the situation of the smaller and smaller competitiveness of single pharmacies, the concentration of pharmaceutical circulation has steadily increased, and in 2016 the tax-inclusive sales of the top 100 pharmaceutical retail sales reached 152.1 billion yuan, up 11.5% YoY.
" industry after a period of mergers and acquisitions, restructuring, industrial concentration increased. In 2016, the market share of the top 100 pharmaceutical wholesalers reached 70.9%, while the top 4 accounted for 32%. Tao Jianhong further pointed out.
Tao Jianhong told the Daily Economic News that small companies without upstream resources and downstream networks are rapidly being eliminated by the market, more capable and self-insured enterprises are forced to choose mergers and acquisitions or mergers and acquisitions, large enterprises through mergers, acquisitions and other integration methods become larger, the number of Chinese pharmaceutical wholesale enterprises is expected to be reduced from the current more than 11,000 to about 3000.
fact, many regional small and medium-sized pharmacies are also trying to "hold the group". Guangdong Good Medical Chain Clinic Alliance, one of the sponsors of the Ke Huasong told reporters that the "two-vote system" this year and next will be in a large area of the country, if the "two-vote system" is fully pushed out, because industry needs high insanity, bargaining power and profits will be improved, the original profit model of commercial companies will be broken.
important stage of change in the circulation industry, the regulatory authorities are also introducing policies to optimize and improve the survival of practitioners.
Tao Jianhong revealed that the Department of Market Order of the Ministry of Commerce and the Department of Pharmacy Supervision of the State Food and Drug Administration have drafted the Draft for Comments, and recently solicited opinions from the commercial authorities of Hunan, Hubei, Hebei and other provinces.
According to the Draft for Comments, in the future, China's retail pharmacies will divide drug retail enterprises into three categories according to the degree of drug safety risk, operating conditions, drug supply capacity and the configuration of pharmaceutical technicians: one type of pharmacy only operates Class B over-the-counter drugs;
based on service capabilities, retail pharmacies are classified from low to high in the same category into A, AA, and AAA grades. Service capacity includes drug supply capacity and traceability management level, pharmaceutical services, pharmacy staffing, information technology and other content.
November 27, a reporter from the Daily Economic News confirmed the document to Huang Xiuxiang, secretary-general of the Hunan Pharmaceutical Circulation Industry Association. He told reporters that on November 17, Hunan Provincial Department of Commerce Joint Association, organized some of the province's chain enterprises, monosome pharmacy representatives to discuss, listened to everyone's views and suggestions on the Draft for Comments.
classification management will promote the rapid development of China's drug retail industry. Huang Xiuxiang believes that the classification and classification management of retail pharmacies is conducive to improving the scientific and effective drug circulation supervision, promoting the standardized operation of retail pharmacies, helping retail pharmacies to find the right positioning, accurate efforts, promote the transformation and upgrading of the industry, effectively protect the safety and convenience of public drug use. (Daily Economic News Network)